Gloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships (PPPs) have the potential to revitalize the discovery and development of first-in-class therapeutics. <ClickHere>
Tag: patent cliff
Drug Patent Expirations and the “Patent Cliff”
Beginning in 2010, the pharmaceutical industry faced one of the biggest waves of drug patent expirations in history, a phenomenon referred to as the “patent cliff.” <ClickHere>
The Structural Changes in the Global Pharmaceutical Marketplace and Their Possible Implications for Intellectual Property
A number of changes have taken place in the global pharmaceutical marketplace over the last decade that are putting pressure on the large research and development (R&D)-based pharmaceutical transnational corporations (TNCs) to change the way they do business.<ClickHere>